Luca Afferi
DissectionInternal medicineRadiologyUrologySurgeryOncologyResectionMortality rateStage (cooking)PathologicalCystectomyBiochemical recurrenceProstatectomyProstate cancerBladder cancerLymph nodeUpper tractIn patientUrothelial carcinomaPerioperativeNephrologyMedicine
51Publications
2H-index
22Citations
Publications 54
Newest
#2Luca AfferiH-Index: 2
Last. David NicolH-Index: 21
view all 24 authors...
Source
Source
#1Luca AfferiH-Index: 2
Last. Maria Carmen MirH-Index: 19
view all 24 authors...
Source
#2Luca AfferiH-Index: 2
Last. Giuseppe SimoneH-Index: 27
view all 18 authors...
Source
#1Elio Mazzone (UniSR: Vita-Salute San Raffaele University)H-Index: 11
#2Giorgio Gandaglia (UniSR: Vita-Salute San Raffaele University)H-Index: 47
Last. Marco MoschiniH-Index: 27
view all 26 authors...
Abstract null null Background null Despite the key importance of magnetic resonance imaging (MRI) parameters, risk classification systems for biochemical recurrence (BCR) in prostate cancer (PCa) patients treated with radical prostatectomy (RP) are still based on clinical variables alone. null null null Objective null We aimed at developing and validating a novel classification integrating clinical and radiological parameters. null null null Design, setting, and participants null A retrospective...
Source
#1Wojciech Krajewski (Wrocław Medical University)H-Index: 12
#2Marco MoschiniH-Index: 27
Last. Romuald Zdrojowy (Wrocław Medical University)H-Index: 14
view all 31 authors...
Purpose This study was carried out to assess whether a prolonged time between primary transurethral resection of non-muscle-invasive bladder cancer (TURB) and implementation of bacillus Calmette-Guerin (BCG) immunotherapy (time to BCG; TTBCG) is associated with adverse oncological survival in patients with T1 high-grade (HG) non-muscle-invasive bladder cancer (NMIBC). Materials and methods Data on 429 patients from 13 tertiary care centers with primary T1HG NMIBC treated with reTURB and maintena...
1 CitationsSource
#1Elio MazzoneH-Index: 11
#2Armando StabileH-Index: 17
Last. Alessandro BerniH-Index: 1
view all 25 authors...
Source
#1Stefania Zamboni (University of Brescia)H-Index: 9
#2Luca AfferiH-Index: 2
Last. Marco MoschiniH-Index: 27
view all 27 authors...
Adjuvant chemotherapy (ACT) is recommended for non-organ-confined bladder cancer (BCa) after radical cystectomy (RC) and pelvic lymph node dissection (PLND), but there are sparse data regarding its specific efficacy in patients with histological variants. The aim of our study was to evaluate the role of ACT on survival outcomes in patients with variant histology in a large multicenter cohort. We retrospectively evaluated data of 3963 patients with BCa treated with RC and bilateral PLND with cura...
Source
#1G. GandagliaH-Index: 3
#1Giorgio GandagliaH-Index: 47
Last. Riccardo CampiH-Index: 2
view all 22 authors...
Source
#1Giorgio GandagliaH-Index: 47
#1G. GandagliaH-Index: 3
Last. Andrea MariH-Index: 31
view all 25 authors...
Source